NCT06598371 2026-05-20A Phase 1/2 Study of KSQ-004EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate Genes Encoding SOCS1 and Regnase-1, in Patients With Select Advanced Solid TumorsM.D. Anderson Cancer CenterPhase 1/2 Recruiting141 enrolled